Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Diego, California 92121


Purpose:

This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa. Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study is designed to characterize safety, procedural factors and clinical effect of OTO-201 administered in subjects with otitis externa.


Criteria:

Inclusion Criteria includes, but is not limited to: - Subject is a male or female aged 6 months to 80 years, inclusive - Subject has a clinical diagnosis of unilateral otitis externa - Subject or subject's caregiver is willing to comply with the protocol and attend all study visits Exclusion Criteria includes, but is not limited to: - Subject has tympanic membrane perforation - Subject has a history of known immunodeficiency disease - Subject has fungal otitis externa, based on clinical signs


NCT ID:

NCT02511561


Primary Contact:

Study Chair
Carl LeBel, PhD
Otonomy, Inc.


Backup Contact:

N/A


Location Contact:

San Diego, California 92121
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.